close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar76Point96
Implied share price

Buy Undervalued by 18.4%

5% margin of safety What's this?

EV / EBITDA
Use Average
JNJ
Johnson & Johnson
PFE
Pfizer Inc.
Change
NVS
Novartis AG (ADR)
Change
SGP
Schering-Plough Corporation
Change
MRK
Merck & Co., Inc.
Change
11.56 9.66 6.93 8.58 25.26 8.11
All amounts in millions
from last financial year
         
Implied Share Price $76.96 $36.68 $78.40 $11.41 $55.71
Market Cap 177,477 162,886 154,643 118,198 117,527
Net Debt -10,885 15,554 15,154 4,798 5,681
Enterprise Value (EV) 166,592 178,440 151,348 51,349 123,208
Revenue 65,030 67,425 59,375 18,502 48,047
EBITDA 17,241 25,744 17,637 2,033 15,184
Percent 26.5 % 38.2 % 29.7 % 11.0 % 31.6 %
EBIT 17,241 20,159 12,881 860 14,574
Percent 26.5 % 29.9 % 21.7 % 4.6 % 30.3 %
Balance Sheet          
Total Assets 102,908 195,014 117,496 28,117 105,781
Total Liabilities 46,329 107,201 51,652 17,588 51,405
Shareholders Equity 56,579 87,813 65,844 10,529 54,376.0

Price history

Comments

No comments yet. Login to comment.